Plast. Reconstr. Surg.
Cost-Effectiveness of Long-Term, Targeted OnabotulinumtoxinA versus Peripheral Trigger Site Deactivation Surgery for the Treatment of Refractory Migraine Headaches.
Schoenbrunner AR, Khansa I, Janis JE
Chronic migraines affect approximately 2 percent of the U.S. population and cost an estimated $17 billion per year. OnabotulinumtoxinA (botulinum toxi ...
Read More
Source: PubMed
J Craniofac Surg 2020 Jan 17
Local Injection of Botulinum Toxin Type A to Prevent Postoperative Scar.
Chen S, Yang Y, Zhang D, Liu Y, Li Y
Physical scars, especially those in the head and neck area, can cause emotional and psychological distress. Recent studies, have suggested that botuli ...
Read More
Source: PubMed
Dermatol Ther 2020 Jan 19
Pyoderma gangrenosum-like lesions provocated by botulinum injections.
Owczarczyk-Saczonek A, Zdanowska N, Wanczyk-Dreczewska B, Wygonowska E, Placek W, Griffiths CC, Griffiths TW
Botulinum toxin (BoNT) is a valuable therapeutic tool with several medical indications and the most popular of all cosmetic procedures worldwide. This ...
Read More
Source: PubMed
Handb Exp Pharmacol 2020 Jan 14
Manufacturing and Clinical Formulations of Botulinum Neurotoxins.
Hasan F
Botulinum Neurotoxins have always existed in nature, but its paralytic effect on humans due to the consumption of poorly preserved food was not recogn ...
Read More
Source: PubMed
